Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Raxibacumab is a human monoclonal antibody intended for the prophylaxis and treatment of inhaled anthrax
The report details the trend, potential and market size of Raxibacumab market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Raxibacumabmarket, defines the market attractiveness level of Raxibacumab market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Raxibacumab industry, describes the types of Raxibacumab market, the applications of major players and the market size, and deeply analyzes the current situation of the global Raxibacumab market and the development prospects and opportunities of Raxibacumab industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Raxibacumab market in Chapter 13.
By Player:
GlaxoSmithKline
By Type:
Treat Inhalational Anthrax
Prevent Inhalational Anthrax
By End-User:
Hospital
Drugs Store
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Raxibacumab Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Raxibacumab Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Raxibacumab Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Raxibacumab Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Raxibacumab Market Analysis and Outlook to 2022
-
7.1 Global Raxibacumab Consumption (2017-2022)
-
7.2 United States Raxibacumab Consumption (2017-2022)
-
7.3 Europe Raxibacumab Consumption (2017-2022)
-
7.4 China Raxibacumab Consumption (2017-2022)
-
7.5 Japan Raxibacumab Consumption (2017-2022)
-
7.6 India Raxibacumab Consumption (2017-2022)
-
7.7 South Korea Raxibacumab Consumption (2017-2022)
8 Region and Country-wise Raxibacumab Market Analysis and Outlook to 2028
-
8.1 Global Raxibacumab Consumption Forecast (2022-2028)
-
8.2 United States Raxibacumab Consumption Forecast (2022-2028)
-
8.3 Europe Raxibacumab Consumption Forecast (2022-2028)
-
8.4 China Raxibacumab Consumption Forecast (2022-2028)
-
8.5 Japan Raxibacumab Consumption Forecast (2022-2028)
-
8.6 India Raxibacumab Consumption Forecast (2022-2028)
-
8.7 South Korea Raxibacumab Consumption Forecast (2022-2028)
9 Global Raxibacumab Market Outlook by Types and Applications to 2022
-
9.1 Global Raxibacumab Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Treat Inhalational Anthrax Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Prevent Inhalational Anthrax Consumption and Growth Rate (2017-2022)
-
9.2 Global Raxibacumab Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Drugs Store Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Raxibacumab Market Outlook by Types and Applications to 2028
-
10.1 Global Raxibacumab Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Treat Inhalational Anthrax Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Prevent Inhalational Anthrax Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Raxibacumab Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Drugs Store Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Raxibacumab Import and Export Analysis (Top 5 Countries)
-
11.1 Global Raxibacumab Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Raxibacumab Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Raxibacumab Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Raxibacumab Market Competitive Analysis
-
14.1 GlaxoSmithKline
-
14.1.1 GlaxoSmithKline Company Details
-
14.1.2 GlaxoSmithKline Raxibacumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 GlaxoSmithKline Raxibacumab Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Raxibacumab
-
Figure Raxibacumab Picture
-
Table Global Raxibacumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Raxibacumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Raxibacumab Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Raxibacumab Consumption by Country (2017-2022)
-
Figure United States Raxibacumab Consumption and Growth Rate (2017-2022)
-
Table Europe Raxibacumab Consumption and Growth Rate (2017-2022)
-
Figure China Raxibacumab Consumption and Growth Rate (2017-2022)
-
Figure Japan Raxibacumab Consumption and Growth Rate (2017-2022)
-
Figure India Raxibacumab Consumption and Growth Rate (2017-2022)
-
Figure South Korea Raxibacumab Consumption and Growth Rate (2017-2022)
-
Figure Global Raxibacumab Consumption Forecast by Country (2022-2028)
-
Figure United States Raxibacumab Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Raxibacumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Raxibacumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Raxibacumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Raxibacumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Raxibacumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Treat Inhalational Anthrax Consumption and Growth Rate (2017-2022)
-
Figure Global Prevent Inhalational Anthrax Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs Store Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Treat Inhalational Anthrax Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prevent Inhalational Anthrax Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugs Store Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Raxibacumab Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Raxibacumab Export by Region (Top 5 Countries) (2017-2028)
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Raxibacumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Raxibacumab Product and Service
-
